Home > Insider Trading > Filing (0001181431-12-004490)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1325879	Aveo Pharmaceuticals Inc	AVEO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1241221	Tuan Ngoc Ha	C/O Aveo Pharmaceuticals, Inc. 75 Sidney Street Cambridge MA 02139	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-09-08	18,349	$0.00	103,741	No	4	J	Direct
Common Stock	Disposition	2011-09-08	18,349	$0.00	151,980	No	4	J	Indirect	Held by GRAT
Common Stock	Disposition	2012-01-26	4,613	$13.37	99,639	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	J	Indirect	Held by GRAT
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	151,980	Indirect	Held by GRAT

Footnotes

The increase of shares of directly held common stock was due to a distribution from Tuan Ha-Ngoc 2009 GRAT to the reporting person on 09/08/2011.
The decrease of shares of indirectly held common stock was due to a distribution from Tuan Ha-Ngoc 2009 GRAT to the reporting person on 09/08/2011.
Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 11, 2011, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
Includes 988 shares acquired on June 30, 2011 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
Includes 511 shares acquired on December 31, 2011 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.